Psychedelic News

Is This the End of Patents on Psilocybin?

Jan 7 • 3 min read

COMPASS Pathways (CMPS)—a leader in the emerging psychedelic therapies space—got dealt a huge blow last week as one of its patents for lab-created psilocybin was formally called into question. On December 15, nonprofit organization Freedom to Operate (FTO) filed a petition essentially claiming that the company’s synthetic psilocybin isn’t a new invention, and therefore can’t…

A New Cross-Sector Partnership Means a Huge Step Forward for MDMA Therapy

Dec 10 • 2 min read

A for-profit corporation and a non-profit organization are teaming up to help bring MDMA-assisted therapy to PTSD patients… Health and wellness fund Vine Ventures and the Multidisciplinary Association for Psychedelic Studies (MAPS) announced that they’re co-creating a special purpose vehicle (SPV). The SPV, which will be called the Regenerative Financing Vine (RFV), will have the…

Observing World Mental Health Day 2021

Oct 8 • 2 min read

This Sunday, October 10 is World Mental Health Day, which is observed to raise awareness of mental health issues around the world and mobilize efforts in support of mental health. October 10 caps the end of Mental Health Week, observed from October 3-9. The World Health Organization’s theme for World Mental Health Day 2021 is…

Mycelial Gallery Blends Crypto and Psychedelics to Raise Money For MAPS; Donates $108k

Aug 26 • 2 min read

There’s no denying the crossover between psychedelics and cryptocurrency. The founders of some of the largest public psychedelic companies are deeply involved in the cryptocurrency and blockchain space. This includes: The founder of ATAI Life Sciences (ATAI), Christian Angermayer, who is also a founder of Cryptology Asset Group Michael Novogratz, an early investor in Compass…

Wesana Health to Acquire Psytech in All Stock Deal

Jul 13 • 2 min read

Recently public life sciences company, Wesana Health (WESA), is set to acquire Psytech Inc. for $21 million CAD in Wesana Health stock. Announcing the news today, Wesana said that Psytech will help contribute to its research of using psilocybin therapy to treat Traumatic Brain Injury (TBI). Psytech’s current business model includes Tovana Solutions, a clinical…

Pages: 1234567891011121314151617181920